December 31, 2001 Wynn Clayton Vice President, Finance TenFold Corporation 180 West Election Road, Suite 100 Salt Lake City, Utah 84020 Re: Retention Bonus Letter Agreement Dear Wynn:Retention Bonus Letter Agreement • April 15th, 2002 • Tenfold Corp /Ut • Services-computer programming services • Utah
This Retention Bonus Letter Agreement ("Agreement") will set forth the mutual understanding between you and TenFold Corporation (the "Company") regarding your agreement to continue your employment with the Company.
Re: Retention Bonus Letter AgreementRetention Bonus Letter Agreement • April 26th, 2010 • Salary. Com, Inc. • Services-prepackaged software
As you know, Salary.com, Inc. (the “Company”) is currently operating under the direction of an Interim Chief Executive Officer (the “Interim CEO”). Among other things, the Interim CEO is overseeing a search for the Company’s regular Chief Executive Officer (the “New CEO”). At this time, the Company believes that your assistance with the search efforts and your service during that transitional period that will follow the New CEO’s commencement of employment (the “New CEO Commencement Date”) is important to the Company and its business goals. To incent you to remain actively employed with the Company at least through the end of this transitional period, the Company is offering you the opportunity to receive a “Retention Bonus” as set forth below. This Letter Agreement is supplemental to and not in lieu of your and the Company’s rights and obligations pursuant to the April 1, 2008 Employment Offer Letter as amended by the December 31, 2008 Amendment to Employment Offer Letter (collectivel
AMENDMENT TO RETENTION BONUS LETTER AGREEMENTRetention Bonus Letter Agreement • November 14th, 2024 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus
This Amendment to Retention Bonus Letter Agreement is entered into as of November 13, 2024, by and between T2 Biosystems, Inc., a Delaware corporation having its principal place of business at 101 Hartwell Avenue, Lexington, Massachusetts 02421 USA (“T2 Bio”) and John Sprague (“Employee”). Capitalized terms used herein without definition shall have the meaning ascribed thereto in the Retention Bonus Letter Agreement (as defined below).
AMENDMENT TO RETENTION BONUS LETTER AGREEMENTRetention Bonus Letter Agreement • November 14th, 2024 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus
This Amendment to Retention Bonus Letter Agreement is entered into as of November 13, 2024, by and between T2 Biosystems, Inc., a Delaware corporation having its principal place of business at 101 Hartwell Avenue, Lexington, Massachusetts 02421 USA (“T2 Bio”) and Michael Gibbs (“Employee”). Capitalized terms used herein without definition shall have the meaning ascribed thereto in the Retention Bonus Letter Agreement (as defined below).
